Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | CASR | P41180 | 2/20 | 0.44 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.42 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11596086 | 0.93 | USP2 (0.58) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL5530973 | 0.93 | USP2 (0.58) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL4135996 | 0.90 | USP2 (0.51) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL15422990 | 0.88 | USP2 (0.55) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL11575286 | 0.86 | USP2 (0.50) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL11575291 | 0.86 | USP2 (0.50) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL4794303 | 0.82 | USP2 (0.58) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL4145616 | 0.82 | USP2 (0.51) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL23615821 | 0.79 | USP2 (0.57) | USP2HTTCASRLPAR5PLA2G2C | |
| SCHEMBL4148593 | 0.79 | USP2 (0.48) | USP2HTTCASRLPAR5PLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | KAO CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | KAO CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-8647649-B2 | Emulsified composition | KAO CORPORATION (JP) | 2014-02-11 | — | — | US | disclosed |
| US-8647649-B2 | Emulsified composition | KAO CORPORATION (JP) | 2014-02-11 | — | — | US | disclosed |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | KAO CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | KAO CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230372207-A1 | CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN | CERT1, CERS2, SGMS2 | USP2 3911/4885HTT 4875/4885CASR 157/4885 |
| US-20120108661-A1 | EMULSIFIED COMPOSITION | CERT1, S1PR4, S1PR3 | USP2 2857/4885HTT 1300/4885CASR 4731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.